Changjiang Health's latest claim news:
On April 30, 2024, Changjiang Runfa Health Industry Co., Ltd. received the Notice of Case Filing from the China Securities Regulatory Commission (No. 0102024013 Zheng Jian Case No. 1) issued by the China Securities Regulatory Commission. Due to the company's suspected illegal information disclosure, in accordance with the Securities Law of the People's Republic of China, the Administrative Punishment Law of the People's Republic of China and other laws and regulations, the CSRC decided to file a case against the company.
The company received a notice from the controlling shareholder, Changjiang Runfa Group Co., Ltd., that Changjiang Runfa Group recently received the "Notice of Case Filing of the China Securities Regulatory Commission" (No. 0102024014 Zheng Jian Case No. ) issued by the China Securities Regulatory Commission.
According to the Securities Law and the Several Provisions of the Supreme People's Court on the Trial of Civil Compensation Cases Arising from False Statements in the Securities Market, listed companies shall be liable for civil compensation if their rights and interests are damaged due to illegal information disclosure and misrepresentation, and the injured investors have the right to claim compensation for losses.
The reference conditions for Changjiang Health's claim are as follows:
Claims can be made if one of the following applies:
1. Those who bought 002435 Changjiang Health between January 1, 2023 and April 29, 2024, and sold or continued to hold it after April 30, 2024 (inclusive).
2. Those who bought 002435 Changjiang Health before April 29, 2024, and sold or continued to hold it after April 30, 2024 (inclusive).
The above claim registration conditions only represent the views of Xie Baoping's lawyer team, and are not used as any securities investment decisions and trading suggestions, and are subject to the final determination of the court.
Yangtze River Health's violation basis:
On April 30, 2024, Changjiang Runfa Health Industry Co., Ltd. received the Notice of Case Filing from the China Securities Regulatory Commission (No. 0102024013 Zheng Jian Case No. 1) issued by the China Securities Regulatory Commission.